CBD oil dosage

CBD oil is currently a hot topic. However, the dosage of CBD oil has not been well described, and there is a lack of concrete, evidence-based instructions. Many suppliers are also legally unable to provide clear dosage recommendations, which leads to considerable uncertainty regarding CBD oil dosage. This article aims to outline a range of CBD dosages that is being researched and experimentally determined in the medical field. The information refers to pure CBD, not to the combination of CBD with other components of the cannabis plant such as THC, other cannabinoids, or terpenes—so-called full-spectrum CBD products. To date, CBD has primarily been used in medicine when conventional treatment methods have failed, usually in combination with other medications. The number of patients treated with CBD and documented in the literature varies greatly depending on the indication, ranging from single cases to hundreds of patients. The dosage of CBD oil should always be discussed with a doctor.
Philip Schmiedhofer, MSc

Autor

Philip Schmiedhofer, MSc

Inhaltsverzeichnis

How is CBD oil properly dosed?

When taking CBD, one usually starts with a low dose.

What side effects can be expected when taking CBD oil?

Side effects from taking pure CBD are extremely rare and usually manifest as diarrhea or soft stools.

How is CBD oil properly dosed?

When taking CBD, one usually starts with a low dose. For example, 2.5 mg per kilogram of body weight or 200 mg per day. The increase takes place after three to four days. The daily dose is usually divided into two administrations after meals. However, it can also be taken all at once, for example after dinner. As already mentioned, a fatty meal significantly increases bioavailability. A response often appears after one to two weeks. Tapering the dose at the beginning and end of a CBD oil treatment is not necessary. CBD is effective over a wide dose range. Due to individual differences in absorption and metabolism, dosing and effects of CBD oil vary. Therefore, one should always start with a low dose. CBD is mainly given as a supportive medication. Therefore, when gradually increasing the dose, attention should be paid to desired as well as undesired effects, especially to a possible adjustment of the accompanying medication. The general motto is: “Start low, go slow, stay low,” meaning start slowly, increase slowly, and avoid overdosing. Nevertheless, it is important to find an effective dose, as otherwise the desired effect cannot occur.

Dosing CBD oil

How do I determine the right CBD dose in drops?

Many people wonder how to determine the right number of drops of CBD oil. The question cannot be answered clearly. It depends on the CBD concentration, the concentration indication, the properties of the oily solution, and the type of device used for dropping. The best way is to weigh the dose with a fine scale. You can also ask the manufacturer how many drops are in a bottle. However, this is often not very precise.

Examples for determining the CBD oil drop dose

  1. If 1 g of CBD oil with 10% CBD is weighed, the dose would amount to 100 mg CBD. You can count the drops, write them down, and dose precisely at the next intake.

  2. The manufacturer states that the 10 ml bottle of 10% CBD oil contains 250 drops – then 25 drops correspond approximately to 100 mg CBD. Please note that an oily solution does not have a density of 1, but 0.9–0.95.

What dosing information do medical studies provide about CBD?

This table can help determine the dosing range of CBD oil for certain medical indications. The dosages listed in the studies serve only as guidance and do not represent a direct dosing recommendation. We recommend always dosing in consultation with a doctor and adjusting if necessary.

Epilepsy

200 - 800 mg/day

up to 1,200 mg/day

CBD was given as an add-on therapy to antiepileptic treatment in patients with seizures of various causes in daily doses between about 200 and 800 mg (up to 1,200 mg/day) in adults and between 2.5 and 25 mg/kg body weight in children (maximum 50 mg/kg). Higher doses may be more effective but also cause more side effects. Possible interactions requiring dose adjustment must be considered. Reducing accompanying medications also reduces side effects.

Anxiety disorders,
PTSD

25 - 300 mg/day

In experimental studies, CBD was given as a single dose between 150 and 900 mg, with heterogeneous results. Under everyday conditions, effects on anxiety parameters were generally observed at a relatively low dose of 25 to 300 mg per day. The treatment duration for anxiety disorders, including post-traumatic stress, lasted between 4 weeks and 5 months.

Chronic pain, neuropathy

400 mg/day

Therapeutic experience with pure CBD in patients with pain is still limited. Effective CBD doses ranged between 100 and 400 mg per day. Generally, better results were achieved in patients who received higher doses.

Treatment with CBD allowed a reduction of accompanying painkillers, including opioids, thereby reducing their side effects. When CBD is given as an add-on therapy, individualized treatment is required.

Cancer

400 mg/day

The effectiveness of pure CBD on tumors was demonstrated many years ago in various animal models. All results unanimously point to a therapeutic effect of CBD. In some combination studies, synergistic effects were generally observed. Initial results (case reports) in patients seem to confirm this.

Drug addiction & withdrawal

400 - 800 mg/day

Patients with various dependencies (heroin, cannabis, nicotine) received CBD in daily doses between 200 and 1,200 mg (mainly 400–800 mg/day) with promising results, although the studies included relatively few subjects.

CBD reduced the reinforcing physiological and positive subjective effects as well as craving and improved overall psychological and cognitive symptoms. Abstinence seems to be maintained even after stopping CBD.

Schizophrenia

600 - 800 mg/day

CBD was given to patients with schizophrenia both as monotherapy and in addition to a stable dose of antipsychotics in daily doses between 600 and 800 mg (maximum 1,500 mg). Some, but not all, patients receiving CBD showed significantly

fewer positive psychotic symptoms. Patients receiving CBD had fewer side effects than those receiving standard antipsychotics.

What side effects can be expected when taking CBD oil?

Side effects when taking pure CBD are very rare and usually manifest as diarrhea or soft stools. Since the first use in 1972, no serious intolerances have been reported with therapy using only cannabidiol. Likewise, no cases of overdose are known. Occasionally, side effects such as elevated liver transaminases or sedation, lethargy, and upper respiratory infections have been reported. These are usually due to accompanying medications (transaminases especially valproate, sedation especially clobazam). Since clobazam, like CBD, is metabolized by CYP3A4 and CYP2C19, simultaneous administration leads to about three times higher bioavailability of clobazam/norclobazam. This can lead to increased side effects from clobazam. To a much lesser extent, this also applies to topiramate and stiripentol. No interaction was observed with valproate. Overall, it can be concluded that the risk of interactions can largely be reduced if the CBD dose is slowly adjusted based on clinical effect and any side effects. At low doses, CBD increases alertness and has no or a negligible effect on driving ability and the ability to operate machinery. At higher doses, sedation is possible, especially when given alongside antiepileptics. This should be considered when increasing the dose. CBD should not be taken during pregnancy and breastfeeding. As a fat-soluble substance, CBD passes into breast milk. Before vaccinations, if possible, CBD intake should be stopped, as it may impair antibody formation.

Philip Schmiedhofer, MSc

Philip Schmiedhofer, MSc

Philip is managing director and co-founder of cannhelp GmbH. With studies in medical engineering and molecular biology, specialized in brain science and focusing on cannabinoids, he is recognized as an expert in the use of cannabinoids in medicine. As a medical device consultant, he also leads the sales of cannmedic and offers specialized advice for medical professionals. His expertise includes the development and sales of cannabinoid-based products. In the field of research, he participates in significant basic research at the Centre for Brain Research of the Medical University of Vienna. As co-founder and current managing director of cannmedic GmbH, a pioneer in the trade of CBD medical devices, he has many years of entrepreneurial experience. Furthermore, he maintains an extensive network in the field and advises internationally operating companies in the area of medical cannabinoids.